Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and FOLFOX with Radiotherapy in Stage III Esophageal Cancer
NCT00578201Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2007
- Primary completion
- Feb 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in esophageal cancer, sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2007; status: completed.
02
Drugs
cetuximab
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00578201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578201.